Results 21 to 30 of about 60,524 (219)

Genetic diversity of Cryptosporidium spp. in captive reptiles [PDF]

open access: yes, 2004
The genetic diversity of Cryptosporidium in reptiles was analyzed by PCR-restriction fragment length polymorphism and sequence analysis of the small subunit rRNA gene.
Xiao, L.   +12 more
core   +2 more sources

Molecular characterization of Cryptosporidium isolates obtained from human immunodeficiency virus-infected individuals living in Switzerland, Kenya, and the United States. [PDF]

open access: yes, 2000
A total of 22 Cryptosporidium isolates from human immunodeficiency virus-infected patients from Kenya, Switzerland, and the United States were examined at three genetic loci: the 18S ribosomal DNA, HSP-70, and acetyl coenzyme A synthetase genes.
Morgan, U.M.   +8 more
core   +2 more sources

Update on Cryptosporidium spp.: highlights from the Seventh International Giardia and Cryptosporidium Conference

open access: yesParasite, 2020
While cryptosporidiosis is recognized as being among the most common causes of human parasitic diarrhea in the world, there is currently limited knowledge on Cryptosporidium infection mechanisms, incomplete codification of diagnostic methods, and a need ...
Widmer Giovanni   +11 more
doaj   +1 more source

Water quality modelling and quantitative microbial risk assessment for uMsunduzi River in South Africa

open access: yesJournal of Water and Health, 2022
South African rivers generally receive waste from inadequate wastewater infrastructure, mines, and farming activities, among others. The uMsunduzi River in KwaZulu-Natal, South Africa, is among these recipients with recorded poor to very poor water ...
Zesizwe Ngubane   +6 more
doaj   +1 more source

Direct Sequencing of Cryptosporidium in Stool Samples for Public Health

open access: yesFrontiers in Public Health, 2019
The protozoan parasite Cryptosporidium is an important cause of diarrheal disease (cryptosporidiosis) in humans and animals, with significant morbidity and mortality especially in severely immunocompromised people and in young children in low-resource ...
Arthur Morris   +5 more
doaj   +1 more source

Identification of novel cryptosporidium genotypes from the Czech Republic [PDF]

open access: yes, 2003
Isolates of Cryptosporidium from the Czech Republic were characterized from a variety of different hosts using sequence and phylogenetic analysis of the 18S ribosomal DNA and the heat-shock (HSP-70) gene.
Ryan, U.   +5 more
core   +2 more sources

Occurrence of Cryptosporidium Oocysts and Helminth Ova on Dried Crayfish (Procambarus clarkii) Sold in Kaduna State, Nigeria

open access: yesFolia Veterinaria, 2021
Cryptosporidium spp. and helminths are responsible for diarrhoal illness in humans and many other animals. The transmission routes of these parasites suggest a risk for human infection through contaminated foods.
Esonu D. O.   +3 more
doaj   +1 more source

Parasitological, microbiological, and antimicrobial resistance profiles of raw and drinking water in a tourist city in the tri-border region of South America

open access: yesJournal of Water and Health, 2022
Despite the large amounts of freshwater available in Brazil, the deterioration of surface water can represent a risk of waterborne disease for national and international tourists. The main goal of this study was to assess the quality of drinking water in
Gustavo Strieder Scherer   +5 more
doaj   +1 more source

Microfluidics for effective concentration and sorting of waterborne protozoan pathogens [PDF]

open access: yes, 2016
We report on an inertial focussing based microfluidics technology for concentrating waterborne protozoa, achieving a 96% recovery rate of Cryptosporidium parvum and 86% for Giardia lamblia at a throughput (mL/min) capable of replacing centrifugation. The
Bridle, H., Jimenez, M.
core   +1 more source

Defining stage-specific activity of potent new inhibitors of Cryptosporidium parvum growth in vitro [PDF]

open access: yes, 2020
Currently, nitazoxanide is the only FDA-approved treatment for cryptosporidiosis; unfortunately, it is ineffective in immunocompromised patients, has varied efficacy in immunocompetent individuals, and is not approved in infants under 1 year of age ...
Funkhouser-Jones, Lisa J   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy